More cuts at troubled Point Therapeutics

The troubles at Point Therapeutics continue as the company announced today that it made major cuts to its management team. On the chopping block were Donald Kiepert, Chairman and CEO; Richard Small, Senior Vice President and CFO; Michael Duffy, Senior Vice President and General Counsel; and Barry Jones, PhD., Senior Vice President and CSO. In May the Boston-based company announced that it would cut its work force by 60 percent after the FDA put a hold on Point's failed lead drug development program.

- see Point's release on the cuts

Related Articles:
Is Point finished? Report
More bad news for Point Therapeutics. Report
Talabostat trials put on hold on discouraging data. Report